Asklepios BioPharmaceutical, Inc. (AskBio)

Asklepios BioPharmaceutical, Inc. (AskBio) is a leading gene therapy company dedicated to developing life-saving medicines and changing lives. Founded in 2001, AskBio is headquartered in Research Triangle Park, North Carolina, and has research and development facilities across the globe. Their mission is to erase genetic disease through the development and delivery of innovative adeno-associated virus (AAV) gene therapies. AskBio's clinical pipeline covers a wide range of central nervous system, neuromuscular, metabolic, and cardiovascular disorders. Their technology and AAV therapeutic assets have been acquired or licensed by major pharmaceutical companies, validating their leadership in the gene therapy field.

AskBio's success is rooted in the groundbreaking research of their scientific co-founder, Dr. Jude Samulski, who was the first to demonstrate that AAV could be cloned for therapeutic purposes. This research propelled the field of gene therapy and inspired AskBio's world-leading gene therapy platform, which is bringing new therapeutics to market and resulting in new methods for lowering the cost of delivery. The company is committed to making their therapies widely accessible and has partnered with Bayer AG to expand their global reach. AskBio's commitment to patients is evident in their patient-centered approach to clinical trials and their ongoing research collaborations with leading institutions, bioscience organizations, and patient advocacy programs.

AskBio offers flexible work options to its employees, allowing for a balance between work and personal life. They promote a collaborative and inclusive culture, encouraging open communication and diverse perspectives. Their benefits package includes generous paid time off, extended paid maternity and parental leave, and flexible work arrangements.

AskBio offers a comprehensive benefits package designed to support employees' financial wellbeing, health, and overall quality of life. This includes competitive salaries, bonus eligibility, long-term incentive plans, retirement plans with a generous match, health, dental, and vision insurance, a variety of health and wellness programs, and generous paid time off, including extended maternity and parental leave. AskBio also fosters a collaborative and inclusive culture with flexible work options, free refreshments and snacks, and an employee recognition program.

Asklepios BioPharmaceutical (AskBio) is a leading gene therapy company dedicated to developing life-saving medicines and changing lives. They are on a mission to erase genetic disease by utilizing their world-leading gene therapy platform and developing innovative AAV vectors, with a particular focus on treating neuromuscular, central nervous system, cardiovascular, and metabolic disorders. AskBio is committed to making their therapies accessible to patients worldwide and collaborates extensively with researchers, advocacy groups, and regulatory agencies to ensure the safe and efficient development and delivery of these life-changing treatments.

AskBio promotes a patient-focused culture that is driven by collaboration, innovation, and a shared commitment to changing lives. They value creative thinking, groundbreaking science, and a collaborative environment where every employee can reach their full potential. Their culture is also reflected in their benefits package, which includes competitive salaries, bonus eligibility, generous paid time off, and flexible work options.

AskBio is committed to building a diverse, equitable, and inclusive workplace where all employees feel valued, respected, and empowered to reach their full potential. They actively seek out and foster a culture that embraces different backgrounds, perspectives, and experiences. This commitment is reflected in their equal opportunity employment policies, benefits package, and the company's core values, which emphasize collaboration and a bias for learning and action.